WEDNESDAY, April 27, 2022 (HealthDay News) -- Pfizer Inc. announced Tuesday that it has asked the U.S. Food and Drug Administration to approve emergency use of its booster shot for children ages 5 to 11 years. The application hinges on a study of 140 ...
from Google Alert - health https://ift.tt/VP0EFws
via IFTTT
0 comments:
Post a Comment